International conference on health care-associated bloodstream infections

American Journal of Infection Control

Volumn 36, Issue 10, 2008, Pages

  Septimus, Edward J ^a  

^a HCA Healthcare System   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOODSTREAM INFECTION; CATHETER INFECTION; CLINICAL RESEARCH; EDITORIAL; HEALTH CARE; HOSPITAL INFECTION; INFECTION CONTROL; INFECTION PREVENTION;

BACTEREMIA; COMMUNITY-ACQUIRED INFECTIONS; CONGRESSES AS TOPIC; CROSS INFECTION; HUMANS;

EID: 57149146442     PISSN: 01966553     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajic.2008.10.011     Document Type: Editorial

References (22)

1. Klevens R.M., Edwards J.R., Richards Jr. C.L., Horan T.C., Gaynes R.P., Pollock D.A., et al. Estimating healthcare-associated infections and deaths in US hospitals, 2002. Public Health Rep 122 (2007) 160-166
2. Pronovost P., Needham D., Berenholtz S., Sinopoli D., Fraser V.J., and Warren D.K. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med 355 (2006) 2725-2732
3. Marschall J., Leone C., Jones M., Nihil D., Fraser V.J., and Warren D.K. Catheter-associated bloodstream infections in general medical patients outside the intensive care unit: a surveillance study. Infect Control Hosp Epidemiol 28 (2007) 905-909
4. Muto C., Herbert C., Harrison E., Edwards J.R., Horan T., Andrus M., et al. Reduction in central line-associated bloodstream infections among patients in intensive care units-Pennsylvania, April 2001-March 2005. MMWR 54 (2005) 1013-1016
5. Bouza E., Alvarado N., Alcala L., Jesus-Perez M., Rincon C., and Munoz P. A randomized and prospective study of 3 procedures for the diagnosis of catheter-related bloodstream infection without catheter withdrawal. Clin Infect Dis 44 (2007) 820-826
6. Shorr A.F., Tabak Y.P., Killian A.D., Vikas G., Liu L.Z., and Kollef M.H. Healthcare-associated bloodstream infection; a distinct entity? Insights from a large US database. Crit Care Med 34 (2006) 2588-2595
7. Shorr AF, Gupta V, Tabak YP, Lui LZ, Kollef MH. Epidemiology of systemic inflammatory response syndrome and organ dysfunction in culture-positive bacteremia patients. Poster presentation 46th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), San Francisco; 2006.
8. Bhutta A., Gilliam C., Honeycutt M., Schexnayder S., Green J., Moss M., et al. Reduction of bloodstream infections associated with catheters in pediatric intensive care unit: stepwise approach. Br Med J 334 (2007) 362-365
9. Henrickson K.J., Axtell R.A., Hoover S.M., Kuhn S.M., Pritchett J., Kehl S.C., et al. Prevention of central venous catheter-related infections and thrombotic events in immunocompromised children by use of vancomycin/ciprofloxacin/heparin flush solution: a randomized, multicenter, double-blind trial. J Clin Oncol 18 (2000) 1269-1278
10. Cookson S.T., Ihrig M., O'Mara, Denny M., Volk H., Banerjee S.N., et al. Increased bloodstream infection rates in surgical patients associated with variation from recommended use and care following implementation of a needleless device. Infect Control Hosp Epidemiol 19 (1998) 23-27
11. Rosenthal V.D., Maki D.G., Salomao R., Moreno C.A., Mehta Y., Higuera F., et al. Device-associated nosocomial infections in 55 intensive care units of 8 developing countries. Ann Intern Med 145 (2006) 582-591
12. Marra A.R., Opilla M., Edmond M.B., and Kirby D.F. Epidemiology of bloodstream infections in patients receiving long-term total parenteral nutrition. J Clin Gastroenterol 41 (2007) 19-28
13. Van den Berghe G., Wouters P., Weekers F., Verwaest C., Bruynincky F., Schetz M., et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 345 (2001) 1359
14. Sherertz R.J., Boger M.S., Collins C.A., Mason L., and Raad I.I. Comparative in vitro efficacies of various catheter lock solutions. Antimicrob Agents Chemother 50 (2006) 1865-1868
15. Opilla M.T., Kirby D.F., and Edmond M.B. Use of ethanol lock therapy to reduce the incidence of catheter-related bloodstream infections in home parenteral nutrition patients. J Parent Ent Nutri 31 (2007) 302-305
16. Aslam S., Trautner B.W., Ramanathan V., and Darouiche R.O.. Combination of tigecycline and n-acetylcysteine reduces biofilm-embedded bacteria on vascular catheters. Antimicrob Agents Chemother 51 (2007) 1556-1558
17. McGowan Jr. J.E. Economic impact of antimicrobial resistance. Emerg Infect Dis 7 (2001) 286-292
18. Paterson D.L., and McCormack J.G. More evidence of the benefits of rational antimicrobial use in clinical practice. Infect Control Hosp Epidemiol 24 (2003) 642-643
19. Salgado C.D., and Farr B.M. Outcomes associated with vancomycin-resistant enterococci: a meta-analysis. Infect Control Hosp Epidemiol 24 (2003) 690-698
20. Pfaller M.A., Diekema D.J., Jones R.N., Sader H.S., Fluit A.C., Hollis R.J., et al. International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole isolates collected from 1997 through 1999 in the SENTRY Antimicrobial Surveillance Program. J Clin Microbiol 39 (2001) 3254-3259
21. Ibrahim E.H., Sherman G., Ward S., Fraser V.J., and Kollef M.H. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 118 (2000) 146-155
22. Garey K.W., Rege M., Pai M.P., Mingo D.E., Suda K.J., Turpin R.S., et al. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. Clin Infect Dis 43 (2006) 25-31